Analystreport

Organogenesis (NASDAQ: ORGO) had its "buy" rating re-affirmed by analysts at BTIG Research.

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report